Home » Topics » Articles » Insight

Insight
RSS

Canadian Biotech Firms Give Investors A Shot In the Arm

Dec. 28, 1998

Selected Canadian Biotechnology Companies With Advanced Product Portfolios

Dec. 28, 1998

New Therapies For Hepatitis Reach The Market

Dec. 21, 1998

FDA Submissions, Approvals And Other Actions: November 1998

Dec. 21, 1998

Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: November 1998

Dec. 21, 1998

Clinical Trial Update: November 1998

Dec. 14, 1998

Cardiovascular Gene Therapy Enters The Clinic

Dec. 14, 1998

Public Financing Of Biotechnology: November 1998

Dec. 7, 1998

Money Raised By Biotech In 1998: January November

Dec. 7, 1998

Other Financings Of Public Biotechnology Companies: November 1998

Dec. 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.